Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Eton Pharmaceuticals, Inc. before investing.

In this article, we go over a few key elements for understanding Eton Pharmaceuticals, Inc.’s stock price such as:

• Eton Pharmaceuticals, Inc.’s current stock price and volume
• Why Eton Pharmaceuticals, Inc.’s stock price changed recently
• Upgrades and downgrades for ETON from analysts
• ETON’s stock price momentum as measured by its relative strength

About Eton Pharmaceuticals, Inc. (ETON)

Before we jump into Eton Pharmaceuticals, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Want to learn more about Eton Pharmaceuticals, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Eton Pharmaceuticals, Inc..

Eton Pharmaceuticals, Inc.’s Stock Price as of Market Close

As of January 23, 2025, 4:00 PM, CST, Eton Pharmaceuticals, Inc.’s stock price was $16.240.

Eton Pharmaceuticals, Inc. is up 10.78% from its previous closing price of $14.660.

During the last market session, Eton Pharmaceuticals, Inc.’s stock traded between $14.763 and $16.620. Currently, there are approximately 25.90 million shares outstanding for Eton Pharmaceuticals, Inc..

Eton Pharmaceuticals, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Eton Pharmaceuticals, Inc. Stock Price History

Eton Pharmaceuticals, Inc.’s (ETON) price is currently up 21.92% so far this month.

During the month of January, Eton Pharmaceuticals, Inc.’s stock price has reached a high of $16.620 and a low of $11.612.

Over the last year, Eton Pharmaceuticals, Inc. has hit prices as high as $15.706 and as low as $3.030. Year to date, Eton Pharmaceuticals, Inc.’s stock is up 21.92%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Eton Pharmaceuticals, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of January 22, 2025,, no analysts have changed their rating of Eton Pharmaceuticals, Inc.’s stock over the last month.

Additionally, you'll want to evaluate Eton Pharmaceuticals, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Eton Pharmaceuticals, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Eton Pharmaceuticals, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Eton Pharmaceuticals, Inc. (ETON) by visiting AAII Stock Evaluator.

Relative Price Strength of Eton Pharmaceuticals, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of January 22, 2025, Eton Pharmaceuticals, Inc. has a weighted four-quarter relative price strength of 46.05%, which translates to a Momentum Score of 97 and is considered to be Very Strong.

Want to learn more about how Eton Pharmaceuticals, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Eton Pharmaceuticals, Inc. Stock Price: Bottom Line

As of January 23, 2025, Eton Pharmaceuticals, Inc.’s stock price is $16.240, which is up 10.78% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Eton Pharmaceuticals, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.